A Study to Evaluate the Efficacy and Safety of Infigratinib in Children and Adolescents With Achondroplasia

QED Investigative Site, San Francisco, California, United States

QED Investigative Site, Aurora, Colorado, United States

QED Investigative Site, Baltimore, Maryland, United States

QED Investigative Site, Columbia, Missouri, United States

QED Investigative Site, Cincinnati, Ohio, United States

QED Investigative Site, Nashville, Tennessee, United States

QED Investigative Site, Madison, Wisconsin, United States

QED Investigative Site, Buenos Aires, Buenos Aires F.D., Argentina

QED Investigative Site, Parkville, Victoria, Australia

QED Investigative Site, Edmonton, Alberta, Canada

QED Investigative Site, London, Ontario, Canada

QED Investigative Site, Ottawa, Ontario, Canada

QED Investigative Site, Montreal, Quebec, Canada

QED Investigative Site, Bron, France

QED Investigative Site, Paris, France

QED Investigative Site, Toulouse, France

QED Investigative Site, Rome, Italy

QED Investigative Site, Bergen, Norway

QED Investigative Site, Oslo, Norway

QED Investigative Site, Singapore, Singapore

QED Investigative Site, Málaga, Spain

QED Investigative Site, Vitoria-Gasteiz, Spain

QED Investigative Site, Bristol, United Kingdom

QED Investigative Site, Glasgow, United Kingdom

QED Investigative Site, London, United Kingdom

QED Investigative Site, Manchester, United Kingdom

QED Investigative Site, Sheffield, United Kingdom